Propensity-matched analysis reveals higher mortality and lower revascularization rates in females with ST-elevation myocardial infarction, highlighting persistent cardiac care disparities.
Cardiovascular Disease is the leading cause of death among women; however acute coronary events tend to be under-managed in females due to atypical presentation & delay in diagnosis. We aim to investigate gender disparities in ST-elevation myocardial infarction (STEMI) outcomes. The national readmission database (2016-2020) was queried to identify hospitalizations for STEMI. Cohorts were stratified based by gender. A propensity score matching (PSM) model matched males and females with STEMI. Pearson's x 2 test was applied to PSM-2 matched cohorts to compare outcomes. Among 1 million hospitalizations for STEMI, 332,165 (31.86%) were females. After propensity matching (N=176,688), females had higher inpatient mortality (14.7% vs 14.5%, aOR: 1.13), cerebrovascular events (3.3% s 2.7%; aOR 1.25), vascular complications (0.9% vs 0.3%; aOR 1.58%) and transfusion requirement (5.8% vs 5.2%, aOR:1.19) [p<0.001]. Females were less likely to receive a PCI (63.1% vs 65.8%, aOR: 0.83) or undergo an emergent CABG (0.8% vs 1.1%, aOR: 0.72) [p<0.001] for acute STEMI. From 2016-2020; STEMI related mortality has decreased from 12.7% to 12.4% in females (p-trend:0.047) while utilization of PCI has increased from 58.2 to 66.2 (p-trend<0.001). Furthermore, female patients had higher readmission rates on 30-day (10.8% vs. 10.2%), 90-day & 180-day intervals (p<0.001). In STEMI, female patients have higher mortality, cardiovascular complications & readmission rates. They less frequently underwent cardiac interventions than males. However, utilization of PCI is increasing, and STEMI associated mortality is decreasing.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: